LMNTD2-AS1

Across TCGA pan-cancer cohorts, LMNTD2-AS1 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LMNTD2-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LMNTD2-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LMNTD2-AS1 is over-expressed in tumor, although a few such as KICH and LUAD show the opposite, repressed pattern.

COAD, KIRC, and BLCA are the cancer types where LMNTD2-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LMNTD2-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	+1.181	<.001	10	view →
KIRC	Male	All	+0.907	<.001	10	view →
BLCA	All	All	+1.240	<.001	6	view →
STAD	All	All	+0.669	.002	5	view →
LIHC	All	All	+0.453	<.001	5	view →
HNSC	Male	II,III,IV	+0.237	.010	5	view →
KICH	All	All	−0.949	<.001	4	view →
BRCA	All	II,III,IV	+0.405	.009	4	view →
CHOL	Female	All	+4.136	<.001	3	view →
LUAD	Male	All	−0.789	.004	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LMNTD2-AS1–COAD

Open the COAD breakdown →